ロード中...
Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases
Metabolic syndrome is estimated to affect more than one in five adults, and its prevalence is growing in the adult and pediatric populations. The most widely recognized metabolic risk factors are atherogenic dyslipidemia, elevated blood pressure, and elevated plasma glucose. Individuals with these c...
保存先:
主要な著者: | , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Hindawi Publishing Corporation
2013
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3678499/ https://ncbi.nlm.nih.gov/pubmed/23781121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/549627 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|